Skip to main content
padlock icon - secure page this page is secure

5′-AMINOIMIDAZOLE-4-CARBOXYAMIDE-RIBONUCLEOSIDE-ACTIVATED GLUCOSE TRANSPORT IS NOT PREVENTED BY NITRIC OXIDE SYNTHASE INHIBITION IN RAT ISOLATED SKELETAL MUSCLE

Buy Article:

$52.00 + tax (Refund Policy)

SUMMARY

1. The nucleoside intermediate 5′-aminoimidazole-4-carboxyamide-ribonucleoside (AICAR) activates skeletal muscle AMP-activated protein kinase (AMPK) and increases glucose uptake. The AMPK phosphorylates neuronal nitric oxide synthase (nNOS)µ in skeletal muscle fibres. There is evidence that both AMPK and nNOSµ may be involved in the regulation of contraction-stimulated glucose uptake.

2. We examined whether both AICAR- and contraction-stimulated glucose uptake were mediated by NOS in rat skeletal muscle.

3. Rat isolated epitrochlearis muscles were subjected in vitro to electrically stimulated contractions for 10 min and/or incubated in the presence or absence of AICAR (2 mmol/L) or the NOS inhibitor NG-monomethyl-l-arginine (l-NMMA; 100 µmol/L).

4. Muscle contraction significantly (P < 0.05) altered the metabolic profile of the muscle. In contrast, AICAR andl-NMMA had no effect on the metabolic profile of the muscle, except that AICAR increased muscle 5′-aminoimidazole-4-carboxyamide-ribonucleotide (ZMP) and AICAR content. Nitric oxide synthase inhibition caused a small but significant (P < 0.05) reduction in basal 3-O-methylglucose transport, which was observed in all treatments. 5′-Aminoimidazole-4-carboxyamide-ribonucleoside significantly increased (P < 0.05) glucose transport above basal, with NOS inhibition decreasing this slightly (increased by 209% above basal compared with 184% above basal with NOS inhibition). Contraction significantly increased glucose transport above basal, with NOS inhibition substantially reducing this (107% increase vs 31% increase). 5′-Aminoimidazole-4-carboxyamide-ribonucleoside plus contraction in combination were not additive on glucose transport.

5. These results suggest that NO plays a role in basal glucose uptake and may regulate contraction-stimulated glucose uptake. However, NOS/nitric oxide do not appear to be signalling intermediates in AICAR-stimulated skeletal muscle glucose uptake.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: AMP-activated protein kinase; contraction; exercise; glucose transport; nitric oxide synthase; nitric oxide synthase inhibition; skeletal muscle

Document Type: Research Article

Affiliations: 1: Department of Physiology, Monash University, Clayton, 2: School of Health Sciences, Deakin University, Burwood and

Publication date: July 1, 2004

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more